Drug Approval | July 10, 2023
Astellas receives FDA priority review for Zolbetuximab biologics license application
Astellas stands on the forefront of healthcare change to turn innovative science into value for patients
Astellas stands on the forefront of healthcare change to turn innovative science into value for patients
PEEK brings a new quality to dental care for patients
As Caeregen’s CDMO partner for CTR-107, Wacker Biotech will produce drug substance at its site in Halle, Germany, and complete clinical trial drug product production at its site in Amsterdam, the Netherlands
Antimicrobial Resistance (AMR) poses a significant threat to global healthcare systems and patient safety
Wider reach for nutraceuticals portfolio in Europe, Turkey and Egypt
APP13007 is a novel aqueous nanosuspension formulation for the treatment of inflammation and pain following ocular surgery
Brexit had a negative impact on NHS staff shortages and worsened the workforce crisis
Revenue from operations at Rs 512.81 crores registered a growth of 17% Y-o-Y for full year FY23
The policymakers, doctors and, patient bodies discuss ways to implement thalassemia control programme nationally
The interaction with key Government Officials and industry leaders led to a joint exploration of possible collaboration and investments in the Healthcare ecosystem between the two countries
Subscribe To Our Newsletter & Stay Updated
